Medical Innovation Acceleration Act of 2025
Official title: To amend the Federal Food, Drug, and Cosmetic Act to exempt from regulation as devices non-invasive diagnostic devices, and for other purposes.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the House Committee on Energy and Commerce.
Medical Innovation Acceleration Act of 2025
This bill exempts noninvasive diagnostic devices from the regulatory authority of the Food and Drug Administration.
The bill defines noninvasive diagnostic device as one that does not penetrate the skin or any other membrane of the body, is not inserted or implanted into the body, causes no more than ephemeral compression or temperature changes to in situ bodily tissues, and does not subject bodily tissues to ionizing radiation.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 88: Medical Innovation Acceleration Act of 2025. 119th Congress. Open America. https://openamerica.io/bill/119-HR-88/
"H.R. 88: Medical Innovation Acceleration Act of 2025." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-HR-88/.
H.R. 88, 119th Cong. (2026), https://openamerica.io/bill/119-HR-88/.
[H.R. 88: Medical Innovation Acceleration Act of 2025](https://openamerica.io/bill/119-HR-88/)